Skip to content
Clinical Trials – home
Sponsor

Dualitybio Inc.

United States 3524 Silverside Road Suite 35b, 19810-4929, United States

About the sponsor

Dualitybio Inc. is involved in clinical research for metastatic breast cancer, with a focus on hormone receptor positive and HER2-low disease. Its studies address treatment needs in patients with advanced breast tumors where HER2 expression is low and targeted options remain limited.

  • Hormone receptor positive breast cancer
  • HER2-low metastatic breast cancer
  • Progression-free survival

The research portfolio in this area reflects interest in therapeutic strategies for advanced breast cancer and biomarker-defined patient groups.

About Specializations

Dualitybio Inc. runs clinical trials in conditions such as Hepatocellular carcinoma, Squamous cell carcinoma of head and neck, Cervix carcinoma, Ovarian cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Hepatocellular carcinoma+5

Not yet recruiting

DB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:Dualitybio Inc.

Study Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Dualitybio Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.